Home LiteratureArticle Details
PMID: 2504879 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Xenogeneic skin graft rejection is especially dependent on CD4+ T cells.

The Journal of experimental medicine ·Vol. 170 ·No. 3 ·1989-09-01 ·Pages 991-6

Pierson RN, Winn HJ, Russell PS, Auchincloss H

Abstract

B6 mice were treated in vivo with anti-CD4, anti-CD8, or both anti-T cell antibodies together in an effort to prolong xenogeneic compared with allogeneic skin graft survival. Mice treated with anti-CD4 antibody showed prolonged survival of xenogeneic monkey or rabbit skin even after they had rejected whole MHC-disparate allogeneic mouse skin. Furthermore, the addition of cyclosporine was synergistic with the anti-CD4 antibody in prolonging graft survival. These results suggest that the cell-mediated response to xenogeneic antigens is especially dependent on CD4+ lymphocytes, a feature shared by the response to allogeneic minor histocompatibility antigens. In addition, the results suggest a possible approach to clinical immunosuppression for some forms of xenogeneic transplantation.

MeSH Terms
Animals Antigens, Differentiation, T-Lymphocyte/physiology CD8 Antigens Graft Rejection Graft Survival Histocompatibility Antigens/physiology Macaca mulatta Mice Mice, Inbred BALB C Mice, Inbred C57BL Rabbits Skin Transplantation T-Lymphocytes/immunology Transplantation, Heterologous
Chemicals
Antigens, Differentiation, T-Lymphocyte CD8 Antigens Histocompatibility Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Pierson R N
Department of Surgery, Massachusetts General Hospital, Boston 02114.
Winn H J
Russell P S
Auchincloss H
References (14)
14 references, click to expand
  1. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
    Transplantation. 1987 Aug;44(2):273-80 PMID: 3114924
  2. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens.
    Immunol Rev. 1987 Aug;98:143-70 PMID: 2958403
  3. Effector cells in allelic H-2 class I-incompatible skin graft rejection.
    J Exp Med. 1987 Oct 1;166(4):982-90 PMID: 3309129
  4. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo.
    Transplantation. 1988 Jun;45(6):1118-23 PMID: 3289152
  5. T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection.
    Immunol Res. 1989;8(2):149-64 PMID: 2659690
  6. Strain variations in the responses of mice to xenografts of skin.
    Transplant Proc. 1977 Mar;9(1):375-7 PMID: 325781
  7. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
    Transplantation. 1986 Dec;42(6):636-42 PMID: 2947360
  8. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.
    J Immunol. 1980 Dec;125(6):2665-72 PMID: 6159417
  9. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    J Immunol. 1983 Nov;131(5):2445-51 PMID: 6415170
  10. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
    Nature. 1984 Dec 6-12;312(5994):548-51 PMID: 6150440
  11. Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
    J Exp Med. 1985 Aug 1;162(2):427-43 PMID: 3160804
  12. The role of T cell accessory molecules in the generation of class II-specific xenogeneic cytolytic T cells.
    J Immunol. 1986 Apr 1;136(7):2358-63 PMID: 2419431
  13. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets.
    Transplantation. 1986 May;41(5):634-9 PMID: 3085299
  14. Responsiveness to HY antigen Ir gene complementation and target cell specificity.
    Immunol Rev. 1977;35:59-75 PMID: 70400
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-09-01
Pages
991-6
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189433
Subset
IM
Grants
NIAID NIH HHS · AI-07759 · United States
NHLBI NIH HHS · HL-18646 · United States
NHLBI NIH HHS · HL-36372 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com